4.2 Article

Immunodeficiency in a patient with microcephalic osteodysplastic primordial dwarfism type I as compared to Roifman syndrome

Journal

BRAIN & DEVELOPMENT
Volume 43, Issue 2, Pages 337-342

Publisher

ELSEVIER
DOI: 10.1016/j.braindev.2020.09.007

Keywords

Microcephalic osteodysplastic primordial dwarfism type I (MOPD I); Roifman syndrome; RNU4ATAC; Pachygyria; Corpus callosum dysgenesis; Immunodeficiency

Funding

  1. AMED, Japan [JP18ek0109280, JP20ek0109486, JP20dm0107090, JP20ek0109301, JP20ek0109348, JP20kk0205012]
  2. JSPS KAKENHI, Japan [JP17H01539, JP19H03621]
  3. Takeda Science Foundation, Japan

Ask authors/readers for more resources

MOPD I, a rare genetic disorder, is characterized by severe intrauterine growth retardation, microcephaly, brain anomalies, and potential immunodeficiencies. The gene responsible for the disorder encodes small nuclear RNA rather than protein.
Background: Microcephalic osteodysplastic primordial dwarfism type I (MOPD I, also known as Taybi-Linder syndrome) is a rare genetic disorder associated with severe intrauterine growth retardation, short stature, microcephaly, brain anomalies, stunted limbs, and early mortality. RNU4ATAC, the gene responsible for this disorder, does not encode a protein but instead the U4atac small nuclear RNA (snRNA), a crucial component of the minor spliceosome. Roifman syndrome is an allelic disorder of MOPD I that is characterized by immunodeficiency complications. Case report: The patient described herein is an 18-year-old woman exhibiting congenital dwarfism and microcephaly with structural brain anomaly. She suffered human herpesvirus 6 (HHV-6)-associated acute necrotizing encephalopathy at the age of one, thereafter resulting in severe psychomotor disabilities. Genetic analysis using gene microarray and whole-exome sequencing could not identify the cause of her congenital anomalies. However, Sanger sequencing revealed a compound heterozygous mutation within RNU4ATAC (NR_023343.1:n.[50G > A];[55G > A]). Immunological findings showed decreases in total lymphocytes, CD4(+) T cells, and T cell regenerative activity. Furthermore, antibodies against varicella-zoster, rubella, measles, mumps, and influenza were very low or negative despite having received vaccinations for these viruses. HHV-6 IgG antibodies were also undetected. Discussion: The patient here exhibited a marked MOPD I phenotype complicated by various immunodeficiencies. Previous studies have not demonstrated immunodeficiency comorbidities within MOPD I subjects, but this report suggests an evident immunodeficiency in MOPD I. Patients with MOPD I should be treated with one of the immunodeficiency syndromes. (C) 2020 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available